ArticleCancer research2014

Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.

Darya Alizadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.